These advancements focus on prodrugs and derivatives to overcome challenges limiting psychedelics' medical use. New patents ...

Roth MKM analyst Jonathan Aschoff maintained a Buy rating on Zevra Therapeutics (ZVRA – Research Report) today and set a price target of ...

Join us for the final broadcast of this year's symposium as John Higgins explains how prodrugs can be pursued early in discovery space in order to optimize drugs’ physicochemical and biopharmaceutical ...

Experiments in which they tested the effectiveness of activating the prodrugs in cell culture on colon and prostrate cancer cells showed the antibody to be effective at therapeutically relevant ...

Prodrugs are medications that start as inactive or less active, and once inside the body, are converted into the active form, ...

Researchers from IOCB Prague have succeeded in preparing compounds capable of activating prodrugs at predetermined locations in the body, enhancing their effectiveness and expediting their action.

Aqsa Arif, a Pakistani PhD student from the LEJ Nanotechnology Centre at the HEJ Research Institute of Chemistry, University ...

Medivir is developing tumor-directed nucleotide oral prodrugs to treat cancers with highly unmet medical needs. The company’s lead drug candidate, MIV-818, is a liver cancer targeted prodrug ...

PureTech-founded Seaport Therapeutics has raised $225m in a Series B financing round to support the development of new prodrug treatments for psychiatric disorders. Seaport plans to use the new ...

Begin your TipRanks Premium journey today. Zevra Therapeutics (ZVRA) Company Description: KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and ...

MAIA will present the results of preclinical studies for its new THIO-based prodrugs, designated as MAIA-2021-20 and MAIA-2022-12, which are lipid-conjugated compounds derived from THIO.